CAT and B-cell chronic lymphocytic leukemia: Differential CAT expression in CLL supports the existence of two main disease subtypes characterized by a disparity in clinical outcome, probably as a consequence of differences not only in underlying genetic lesions, epigenetic changes, activated signaling pathways, and interactions with the microenvironment, but also in the redox machinery.